Trade Setup for March 23: Nifty remains in sell-on-rise mode with 23,000 holding the key
The near-term trend for the Nifty remains weak and analysts expect the current bounce to be a sell-on-rise opportunity.
Latest News
Jubilant Ingrevia begins dispatches from Bharuch plant in Gujarat under CDMO contract
Shares of Jubilant Ingrevia Ltd ended at ₹584.75, up by ₹13.55, or 2.37%, on the BSE.
Tata Capital faces ₹413 crore income tax reassessment for FY 2017-18, plans appeal
Shares of Tata Capital Ltd ended at ₹317.25, up by ₹4.35, or 1.39%, on the BSE.
Divi’s Laboratories gets draft tax order proposing ₹571 crore additions for FY23
Shares of Divi’s Laboratories Ltd ended at ₹6,109.55, up by ₹131.95, or 2.21%, on the BSE.
Trideep Bhattacharya flags risk premium reset amid volatility, stresses data-driven investing
Trideep Bhattacharya, CIO-Equities at Edelweiss AMC, said investors should avoid reacting to short-term news and instead rely on data before taking calls. He notes that…
Vakrangee partners Bajaj General Insurance for health, motor, home and travel policies
Shares of Vakrangee Limited ended at ₹5.71, down by ₹0.100, or 1.72%, on the BSE.
IDBI Bank divestment faces delay as valuation gap & deal structure concerns persist: Abizer Diwanji
Experts point to the large transaction size, investor demand for management control and the involvement of multiple stakeholders as key factors. While similar deals in…
Omaxe subsidiaries secure RERA approvals for two residential plot developments in Punjab and UP
On Friday (March 20), shares of Omaxe Ltd ended at ₹71.07, up by ₹0.28, or 0.40%, on the BSE.
Obesity & diabetes drug opportunity opens new pharma value chain bets in India: Ramesh Mantri
Ramesh Mantri, CIO, WhiteOak Capital AMC, said that the falling prices are expected to improve access to new therapies, supporting wider adoption in a market…
UGRO Capital approves ₹205 crore NCD issuance via private placement
On Friday (March 20), shares of Ugro Capital Ltd ended at ₹94.15, up by ₹2.00, or 2.17%, on the BSE.